3,4-methylenedioxyethamphetamine has been researched along with Chemical Dependence in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 14 (66.67) | 18.2507 |
2000's | 3 (14.29) | 29.6817 |
2010's | 3 (14.29) | 24.3611 |
2020's | 1 (4.76) | 2.80 |
Authors | Studies |
---|---|
Bello, D; Luo, J; Pagsuyoin, S | 1 |
Burgueño, MJ; Castro, MÁ; Mateos-Campos, R; Sánchez, S | 1 |
Fatehi, M; Haw, CS; Heran, MKS; Nugent, JP | 1 |
Browne, G; McGettigan, S; Ronan, GP; Ronan, N | 1 |
Cole, JC; Sumnall, HR | 1 |
Bronselaer, K; De Feyter, K; De Munnynck, K; Sabbe, M; Smets, G; Van de Voorde, W | 1 |
Borchardt, D; Gouzoulis, E; Hermle, L | 1 |
Bodenham, A; Hardern, R; Tehan, B | 1 |
Korten, JJ; Roebroek, RM | 1 |
Clark, JC; Forrest, AR; Milroy, CM | 1 |
Brown, ER; Jarvie, DR; Simpson, D | 1 |
Dalgarno, P; Shewan, D | 1 |
Ryan, JM; Stell, JM | 1 |
Burroughs, A; Dhillon, A; Fidler, H; Gertner, D | 1 |
Gouzoulis-Mayfrank, E; Hermle, L; Kovar, KA; Sass, H | 1 |
Kikura, R; Mieczkowski, T; Nakahara, Y; Tagliaro, F | 1 |
Barrio Anta, G; de la Fuente de Hoz, L; Rodríguez Arenas, MA; Sánchez Payá, J; Vicente Orta, J | 1 |
Bogusz, MJ | 1 |
Dirnhofer, R; Keller, T; Miki, A; Regenscheit, P; Schneider, A; Tsuchihashi, H | 1 |
Felgenhauer, N; Zilker, T | 1 |
Allen, DL; Oliver, JS | 1 |
4 review(s) available for 3,4-methylenedioxyethamphetamine and Chemical Dependence
Article | Year |
---|---|
Altered states: the clinical effects of Ecstasy.
Topics: 3,4-Methylenedioxyamphetamine; Brain; Clinical Trials as Topic; Cognition Disorders; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 2003 |
Hyperthermia associated with 3,4-methylenedioxyethamphetamine ('Eve').
Topics: 3,4-Methylenedioxyamphetamine; Adult; Designer Drugs; Fever; Humans; Male; Poisoning; Substance-Related Disorders | 1993 |
[Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
Topics: 3,4-Methylenedioxyamphetamine; Animals; Designer Drugs; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Risk Factors; Substance Withdrawal Syndrome; Substance-Related Disorders | 1996 |
[Poisoning with amphetamines and designer drugs].
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Designer Drugs; Drug Overdose; Humans; Illicit Drugs; Internal Medicine; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin Syndrome; Substance-Related Disorders | 1999 |
17 other study(ies) available for 3,4-methylenedioxyethamphetamine and Chemical Dependence
Article | Year |
---|---|
Long-term wastewater-based surveillance and impacts of the COVID-19 pandemic on drug use trends in a U.S. Northeast rural town.
Topics: Amphetamine; Cocaine; COVID-19; Fentanyl; Humans; Hydrocodone; Methadone; N-Methyl-3,4-methylenedioxyamphetamine; Pandemics; Rural Population; Substance Abuse Detection; Substance-Related Disorders; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2023 |
[High-risk drug use: epidemiological pattern through hair testing in the forensic context].
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Amphetamine; Cannabinoids; Cocaine; Cross-Sectional Studies; Female; Forensic Sciences; Gas Chromatography-Mass Spectrometry; Hair; Heroin; Humans; Illicit Drugs; Ketamine; Male; Methadone; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Spain; Substance Abuse Detection; Substance-Related Disorders; Young Adult | 2019 |
Emergency Embolization of Artery of Adamkiewicz Pseudoaneurysm Following Methylenedioxymethamphetamine Abuse.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Aneurysm, False; Arteries; Computed Tomography Angiography; Embolization, Therapeutic; Humans; Magnetic Resonance Imaging; Male; Subarachnoid Hemorrhage; Substance-Related Disorders; Tomography Scanners, X-Ray Computed | 2019 |
Serotonin syndrome unmasking thyrotoxicosis.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Aftercare; Anti-Arrhythmia Agents; Antithyroid Agents; Carbimazole; Delirium; Diagnosis, Differential; Humans; Intensive Care Units; Male; Propranolol; Serotonin Syndrome; Substance-Related Disorders; Thyrotoxicosis; Thyrotropin; Treatment Outcome; Tremor | 2019 |
Amphetamine toxicity in the emergency department.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamines; Emergency Service, Hospital; Fatal Outcome; Female; Humans; Male; Substance-Related Disorders | 2005 |
A case of toxic psychosis induced by 'eve' (3,4-methylene-dioxyethylam-phetamine)
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Psychoses, Substance-Induced; Substance-Related Disorders | 1993 |
[Epileptic insults, cerebral infarction and rhabdomyolysis as complications of amphetamine use].
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Cerebral Infarction; Designer Drugs; Epilepsy, Generalized; Humans; Male; Rhabdomyolysis; Substance-Related Disorders | 1996 |
Pathology of deaths associated with "ecstasy" and "eve" misuse.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Brain; Humans; Liver; Male; Myocardium; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 1996 |
Use of drugs at 'raves'.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Catha; Central Nervous System Stimulants; Dancing; Designer Drugs; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Plant Extracts; Scotland; Substance-Related Disorders; Surveys and Questionnaires | 1995 |
Ecstasy and neurodegeneration. ...such as ketamine.
Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Drug Contamination; Ephedrine; Hallucinogens; Humans; Ketamine; Substance-Related Disorders; Tablets | 1996 |
Ecstasy and neurodegeneration. gamma-Hydroxybutyrate is a new recreational drug that may lead to loss of consciousness.
Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Diagnosis, Differential; Humans; Seizures; Sodium Oxybate; Substance-Related Disorders; Unconsciousness | 1996 |
Chronic ecstasy (3,4-methylenedioxymetamphetamine) abuse: a recurrent and unpredictable cause of severe acute hepatitis.
Topics: 3,4-Methylenedioxyamphetamine; Acute Disease; Adolescent; Adult; Biopsy; Chemical and Drug Induced Liver Injury; Female; Humans; Male; Recurrence; Substance-Related Disorders | 1996 |
Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Gas Chromatography-Mass Spectrometry; Hair; Hallucinogens; Humans; Lactates; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Substance Abuse Detection; Substance-Related Disorders | 1997 |
[Epidemiology of designer drug use in Spain].
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Cocaine; Designer Drugs; Female; Heroin; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Spain; Substance-Related Disorders | 1997 |
On acute poisoning with amphetamines.
Topics: 3,4-Methylenedioxyamphetamine; Acute Disease; Designer Drugs; Heroin; Humans; Narcotic Antagonists; Narcotics; Substance-Related Disorders | 1998 |
Detection of designer drugs in human hair by ion mobility spectrometry (IMS).
Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Forensic Medicine; Hair; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Sensitivity and Specificity; Spectrometry, Mass, Secondary Ion; Substance-Related Disorders | 1998 |
The use of supercritical fluid extraction for the determination of amphetamines in hair.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Designer Drugs; Gas Chromatography-Mass Spectrometry; Hair; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Reference Values; Reproducibility of Results; Substance Abuse Detection; Substance-Related Disorders | 2000 |